However, there are also genome-wide copy number alterations in melanoma: amplification affects the melanoma oncogenes, as well as CCND1 (cyclin D1) and MITF, while loss of heterozygosity (LOH) or complete loss may affect CDKN2A (p16) and PTEN [1]. The gene discussed is CCND1; the disease is melanoma.